GL Sciences Inc. (TYO:7705)
2,759.00
+53.00 (1.96%)
Inactive · Last trade price
on Sep 26, 2024
GL Sciences Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 7,233 | 7,451 | 6,556 | 6,119 | 6,358 | 5,891 | Upgrade
|
Cash & Short-Term Investments | 7,233 | 7,451 | 6,556 | 6,119 | 6,358 | 5,891 | Upgrade
|
Cash Growth | -9.06% | 13.65% | 7.14% | -3.76% | 7.93% | 8.79% | Upgrade
|
Receivables | 11,726 | 12,747 | 11,671 | 10,344 | 9,198 | 8,402 | Upgrade
|
Inventory | 13,324 | 12,449 | 11,177 | 7,975 | 7,057 | 5,960 | Upgrade
|
Other Current Assets | 564 | 703 | 634 | 391 | 360 | 145 | Upgrade
|
Total Current Assets | 32,847 | 33,350 | 30,038 | 24,829 | 22,973 | 20,398 | Upgrade
|
Property, Plant & Equipment | 17,170 | 17,065 | 17,026 | 14,639 | 12,704 | 10,533 | Upgrade
|
Long-Term Investments | 4,802 | 4,513 | 3,449 | 3,039 | 2,521 | 1,807 | Upgrade
|
Other Intangible Assets | 642 | 637 | 496 | 466 | 483 | 351 | Upgrade
|
Other Long-Term Assets | - | 2 | 2 | 2 | 2 | 2 | Upgrade
|
Total Assets | 55,461 | 55,567 | 51,011 | 42,975 | 38,683 | 33,091 | Upgrade
|
Accounts Payable | 3,668 | 3,976 | 4,077 | 3,907 | 3,323 | 3,025 | Upgrade
|
Accrued Expenses | 405 | 836 | 788 | 726 | 610 | 565 | Upgrade
|
Short-Term Debt | 3,476 | 3,276 | 2,868 | 2,113 | 2,131 | 1,425 | Upgrade
|
Current Income Taxes Payable | 312 | 883 | 1,192 | 776 | 780 | 306 | Upgrade
|
Other Current Liabilities | 1,807 | 1,636 | 1,389 | 1,231 | 961 | 971 | Upgrade
|
Total Current Liabilities | 9,668 | 10,607 | 10,314 | 8,753 | 7,805 | 6,292 | Upgrade
|
Long-Term Debt | 3,201 | 3,431 | 4,118 | 1,846 | 2,431 | 1,425 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 728 | 97 | 97 | 97 | 97 | Upgrade
|
Other Long-Term Liabilities | 1,303 | 264 | 590 | 498 | 381 | 236 | Upgrade
|
Total Liabilities | 14,508 | 15,359 | 15,435 | 11,447 | 10,928 | 8,350 | Upgrade
|
Common Stock | 1,207 | 1,207 | 1,207 | 1,207 | 1,207 | 1,207 | Upgrade
|
Additional Paid-In Capital | 1,815 | 1,815 | 1,815 | 1,815 | 1,815 | 1,820 | Upgrade
|
Retained Earnings | 28,923 | 28,839 | 26,075 | 23,089 | 20,704 | 18,755 | Upgrade
|
Treasury Stock | -509 | -509 | -509 | -509 | -509 | -509 | Upgrade
|
Comprehensive Income & Other | 2,740 | 2,290 | 1,301 | 1,200 | 668 | 118 | Upgrade
|
Total Common Equity | 34,176 | 33,642 | 29,889 | 26,802 | 23,885 | 21,391 | Upgrade
|
Minority Interest | 6,777 | 6,566 | 5,687 | 4,726 | 3,870 | 3,350 | Upgrade
|
Shareholders' Equity | 40,953 | 40,208 | 35,576 | 31,528 | 27,755 | 24,741 | Upgrade
|
Total Liabilities & Equity | 55,461 | 55,567 | 51,011 | 42,975 | 38,683 | 33,091 | Upgrade
|
Total Debt | 6,677 | 6,707 | 6,986 | 3,959 | 4,562 | 2,850 | Upgrade
|
Net Cash (Debt) | 556 | 744 | -430 | 2,160 | 1,796 | 3,041 | Upgrade
|
Net Cash Growth | - | - | - | 20.27% | -40.94% | 3.79% | Upgrade
|
Net Cash Per Share | 54.19 | 72.52 | -41.91 | 210.53 | 175.05 | 296.40 | Upgrade
|
Filing Date Shares Outstanding | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | Upgrade
|
Total Common Shares Outstanding | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | Upgrade
|
Working Capital | 23,179 | 22,743 | 19,724 | 16,076 | 15,168 | 14,106 | Upgrade
|
Book Value Per Share | 3331.09 | 3279.03 | 2913.22 | 2612.34 | 2328.01 | 2084.91 | Upgrade
|
Tangible Book Value | 33,534 | 33,005 | 29,393 | 26,336 | 23,402 | 21,040 | Upgrade
|
Tangible Book Value Per Share | 3268.52 | 3216.94 | 2864.88 | 2566.92 | 2280.93 | 2050.70 | Upgrade
|
Order Backlog | - | 9,725 | 10,568 | 8,937 | 6,050 | 5,466 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.